Millrace Asset Group’s Evolent Health EVH Stock Holding History

Millrace Asset Group’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-130,732	Closed	-$710K	–	80
2020 Q1	$710K	Buy	130,732 +58,972	+82%	+$527K	1.07%	49
2019 Q4	$649K	Buy	+71,760	New	+$583K	0.71%	56
2017 Q3	–	Sell	-60,000	Closed	-$1.52M	–	66
2017 Q2	$1.52M	Sell	60,000 -12,000	-17%	-$289K	1.44%	37
2017 Q1	$1.61M	Buy	+72,000	New	+$1.38M	1.63%	34
2016 Q2	–	Sell	-77,400	Closed	-$817K	–	50
2016 Q1	$817K	Buy	+77,400	New	+$800K	1.13%	41

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Millrace Asset Group's EVH Position: Q2 2020 in Review

Millrace Asset Group sold out of Evolent Health (EVH) in Q2 2020, closing a stake of 130,732 shares — an estimated $710K sold.

Millrace Asset Group first reported a position in EVH in Q1 2016 and held it in 5 quarters. The position peaked at $1.61M in Q1 2017. 136 funds tracked by Wall St. Rank hold EVH as of Q2 2020.

Millrace Asset Group reported no remaining Evolent Health position as of Q2 2020 after selling out during the quarter.
Millrace Asset Group sold 130,732 Evolent Health shares in Q2 2020, an estimated $710K.
Millrace Asset Group first reported a position in Evolent Health in Q1 2016 and held it in 5 quarters.
Millrace Asset Group's Evolent Health position peaked at $1.61M in Q1 2017.
136 funds tracked by Wall St. Rank held Evolent Health as of Q2 2020.

Based on Millrace Asset Group's 13F filing for Q2 2020, filed 13 Aug 2020.